Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 2
1982 4
1983 4
1984 5
1985 1
1986 3
1988 4
1989 1
1990 8
1991 10
1992 13
1993 6
1994 7
1995 7
1996 19
1997 25
1998 21
1999 11
2000 8
2001 15
2002 13
2003 12
2004 8
2005 2
2006 9
2007 10
2008 5
2009 11
2010 7
2011 15
2012 22
2013 24
2014 34
2015 17
2016 16
2017 17
2018 18
2019 11
2020 17
Text availability
Article attribute
Article type
Publication date

Search Results

418 results
Results by year
Filters applied: . Clear all
Page 1
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.
McCubrey JA, Lertpiriyapong K, Steelman LS, Abrams SL, Yang LV, Murata RM, Rosalen PL, Scalisi A, Neri LM, Cocco L, Ratti S, Martelli AM, Laidler P, DuliƄska-Litewka J, Rakus D, Gizak A, Lombardi P, Nicoletti F, Candido S, Libra M, Montalto G, Cervello M. McCubrey JA, et al. Among authors: montalto g. Aging (Albany NY). 2017 Jun 12;9(6):1477-1536. doi: 10.18632/aging.101250. Aging (Albany NY). 2017. PMID: 28611316 Free PMC article. Review.
RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma.
Akula SM, Abrams SL, Steelman LS, Emma MR, Augello G, Cusimano A, Azzolina A, Montalto G, Cervello M, McCubrey JA. Akula SM, et al. Among authors: montalto g. Expert Opin Ther Targets. 2019 Nov;23(11):915-929. doi: 10.1080/14728222.2019.1685501. Epub 2019 Nov 4. Expert Opin Ther Targets. 2019. PMID: 31657972 Review.
The effect of bergamot on dyslipidemia.
Giglio RV, Patti AM, Nikolic D, Li Volti G, Al-Rasadi K, Katsiki N, Mikhailidis DP, Montalto G, Ivanova E, Orekhov AN, Rizzo M. Giglio RV, et al. Among authors: montalto g. Phytomedicine. 2016 Oct 15;23(11):1175-81. doi: 10.1016/j.phymed.2015.12.005. Epub 2015 Dec 30. Phytomedicine. 2016. PMID: 26851838 Review.
PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk.
Nikolic D, Castellino G, Banach M, Toth PP, Ivanova E, Orekhov AN, Montalto G, Rizzo M. Nikolic D, et al. Among authors: montalto g. Curr Pharm Des. 2017 Mar 26;23(6):894-902. doi: 10.2174/1381612822666161006151134. Curr Pharm Des. 2017. PMID: 27719644 Review.
Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia.
Patti AM, Toth PP, Giglio RV, Banach M, Noto M, Nikolic D, Montalto G, Rizzo M. Patti AM, et al. Among authors: montalto g. Curr Pharm Des. 2017;23(17):2496-2503. doi: 10.2174/1381612823666170317145851. Curr Pharm Des. 2017. PMID: 28317482 Review.
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms.
Rizzo M, Nikolic D, Patti AM, Mannina C, Montalto G, McAdams BS, Rizvi AA, Cosentino F. Rizzo M, et al. Among authors: montalto g. Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):2814-2821. doi: 10.1016/j.bbadis.2018.05.012. Epub 2018 May 18. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29778663 Free article. Review.
Sexually Transmitted Infections: Prevention, Diagnosis, and Treatment in Primary Care.
Montalto GJ. Montalto GJ. Pediatr Ann. 2019 Sep 1;48(9):e370-e375. doi: 10.3928/19382359-20190815-02. Pediatr Ann. 2019. PMID: 31505011 Review.
GSK-3 as potential target for therapeutic intervention in cancer.
McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Sokolosky M, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Rakus D, Gizak A, Demidenko ZN, Cocco L, Martelli AM, Cervello M. McCubrey JA, et al. Among authors: montalto g. Oncotarget. 2014 May 30;5(10):2881-911. doi: 10.18632/oncotarget.2037. Oncotarget. 2014. PMID: 24931005 Free PMC article. Review.
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases.
McCubrey JA, Lertpiriyapong K, Steelman LS, Abrams SL, Cocco L, Ratti S, Martelli AM, Candido S, Libra M, Montalto G, Cervello M, Gizak A, Rakus D. McCubrey JA, et al. Among authors: montalto g. Adv Biol Regul. 2017 Aug;65:77-88. doi: 10.1016/j.jbior.2017.05.005. Epub 2017 May 26. Adv Biol Regul. 2017. PMID: 28579298 Review.
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases.
Licata A, Puccia F, Lombardo V, Serruto A, Minissale MG, Morreale I, Giannitrapani L, Soresi M, Montalto G, Almasio PL. Licata A, et al. Among authors: montalto g. Eur J Gastroenterol Hepatol. 2018 Feb;30(2):226-232. doi: 10.1097/MEG.0000000000001030. Eur J Gastroenterol Hepatol. 2018. PMID: 29120909 Review.
418 results
Jump to page
Feedback